Sanjeebani Clinic Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.40 M
as on 24-10-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 41.90 Cr
as on 24-10-2024
- Revenue 5.62%
(FY 2023)
- Profit 13.29%
(FY 2023)
- Ebitda 14.71%
(FY 2023)
- Net Worth 29.18%
(FY 2023)
- Total Assets 14.31%
(FY 2023)
About Sanjeebani Clinic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹41.90 Cr.
Swarnava Roy and Dipten Ghosh serve as directors at the Company.
- CIN/LLPIN
U85110WB2004PTC098872
- Company No.
098872
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sanjeebani Clinic?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Swarnava Roy | Director | 17-Jun-2004 | Current |
Dipten Ghosh | Additional Director | 23-Dec-2009 | Current |
Financial Performance of Sanjeebani Clinic.
Sanjeebani Clinic Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.62% increase. The company also saw a substantial improvement in profitability, with a 13.29% increase in profit. The company's net worth Soared by an impressive increase of 29.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sanjeebani Clinic?
In 2023, Sanjeebani Clinic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Kolkata Recipe And Multicuisine Private LimitedActive 6 years 24 days
Swarnava Roy is a mutual person
- Dhanantari Health Care Private LimitedActive 6 years 9 months
Swarnava Roy and Dipten Ghosh are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Bank Of India Creation Date: 20 Sep 2024 | ₹5.90 Cr | Open |
Others Creation Date: 15 Mar 2024 | ₹4.05 Cr | Open |
Bank Of India Creation Date: 24 Nov 2023 | ₹2.55 Cr | Open |
How Many Employees Work at Sanjeebani Clinic?
Sanjeebani Clinic has a workforce of 81 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanjeebani Clinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanjeebani Clinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.